Background. Cardiac arrhythmias are common in pregnant women. In most cases, they do not require treatment other than rest, electrolyte supplementation and avoidance of strong coffee and tea. Persistent arrhythmia or the ventricular rate running at a high frequency may cause hemodynamic deterioration in the fetus or in both the fetus and the mother.
Introduction
Cardiac arrhythmias are common in pregnant women. 1, 2 In most cases, they do not require treatment other than rest, electrolyte supplementation and avoidance of strong coffee and tea. Persistent arrhythmia or rapid ventricular rate response may cause hemodynamic deterioration in the fetus or in both the fetus and the mother. 1, 3 Therefore, these arrhythmias should be treated early and effectively. In cases of arrhythmia with severe hemodynamic compromise resistant to medical therapy and recurring after direct current cardioversion, ablation may be the treatment of choice. 1 The risk tied to the ablation procedure in pregnant women is related to the use of X-rays, anesthetic agents, thromboembolic complications and the difficulty of obtaining vascular access. 1, 4 The aim of this study was to assess the prevalence and characteristics of arrhythmias in pregnant women qualified for ablation and the feasibility of these operations without the use of X-rays, as well as to present the specific features of these interventions.
Material and methods
The study was designed as a retrospective case control study. A database of medical records of 5,059 patients with arrhythmia treated with catheter ablation from January 2003 to February 2014 was analyzed. The study group consisted of 11 pregnant women (16-32 hbd) aged 31 ± 6.
The control group consisted of 111 women aged 15-50 years (34 ± 10), scheduled for ablation in 2012. In 2012, a total of 690 ablation procedures were performed.
The medical records of the selected study and control groups were retrieved and following data were analyzed: age, the reason for the ablation procedure, the ablation duration, the number of radiofrequency applications, the total duration of radiofrequency applications, comorbidities and whether a woman is currently pregnant.
In pregnant women, data regarding parity, gestational age at the time of ablation procedure, previous treatment of arrhythmia, and the history of arrhythmias during previous pregnancies was also analyzed.
Ablation procedure
All of the pregnant women gave their permission for ablation and accepted the possibility of using X-ray if necessary. During all of the procedures we tried to reduce fluoroscopy as much as possible. The study protocol was approved by the Bioethics Committee of the Wroclaw Medical University.
Statistical analysis
The continuous variables were presented as mean and standard deviations or median and interquartile range and compared with Student t-test or Mann Whitney U test. The discrete variables were presented as numbers and percentages and compared with c 2 test. P values less than 0.05 were considered statistically significant.
Results

Demographics
Pregnant women who underwent ablation accounted for 0.2% of the population treated with this method in the analyzed period. Ablations in women of reproductive age constituted 15.5% of procedures; ablations in pregnant women were 1.4% of the procedures performed in women in reproductive age. Table 1 presents data on the medical history of the study group. The mean age of women in the study group was slightly, but insignificantly, lower than those in the control group (30.8 ± 5.6 vs. 34.3 ± 10.0 years, p = 0.3). However, the percentage of women under 40 in the study group was significantly higher than in the control group (100 vs. 62.2% p < 0.05).
Medical history
In pregnant women the arrhythmia was most commonly present before pregnancy but worsened during pregnancy.
Arrhythmia characteristics
In Table 2 characteristics of arrhythmias and comorbidities in the study and control group are presented. Before the ablation in pregnant women, 2 (18.2%) had electrical cardioversion and one was treated with amiodarone. Time from arrhythmia onset (years) median (IQR) 5.0 (3.0-14.0) Parity first pregnancy n (%) second pregnancy n (%) third pregnancy n (%) fourth pregnancy n (%)
Past history of arrhythmias during pregnancy arrhythmia was not a problem arrhythmia was a problem 4 (36.4) 1 (9.1) Ejection fraction < 55% n (%) 3 (27.3)
Ablation procedures
All of the procedures in pregnant women have been performed using solely electronaatomical systems (CAR-TO -9, EnSite -1) with no fluoroscopy use. Nine women underwent RF ablation and one woman underwent cryoablation. Figs. 1 and 2 contain representative CARTO and EnSite mappings.
Vascular access
In pregnant women catheters were introduced to the right heart by the right internal jugular vein (1 or 2 introducers). In one patient, femoral transaortic approach was used for the left side accessory pathway ablation. Difficulty in obtaining vascular access occurred in 1 patient who withdrew her consent to perform the procedure after the anesthesiologist was unable to catheter her internal jugular vein. A ultrasonography revealed a vascular anomaly.
In the control group all procedures were performed using the femoral approach, and the electroanatomical system was used in 61 patients (55%). In this group fluoroscopyfree ablation was performed in 23 patients (20.7%).
Second stage ablation in study group
In two cases in the study group, the ablation procedure was planned for two sessions: the first session to provided symptoms control and the second session, carried out after birth, to eliminate arrhythmia substrate. In one of these cases first session proved to be sufficient for ending arrhythmia and the second session was unnecessary.
Pregnancy outcome
The procedures were not associated with any complications. All women ablated during the pregnancy gave birth to healthy full-term children. Congenital heart disease, n (%) 0 (0) 2 (1.8) ns.
Inherited electrical disturbances, n (%) 0 (0) 1 (1.8) ns.
Women with comorbidities, n (%) 2 (18.2) 22 (20.0) ns. Fig. 1 . Carto map performed during sinus rhythm in a woman at 24 weeks of gestation, who had slow atrioventricular pathway ablation. Pink dots define the tricuspid valve area, white dots indicate the vena cava inferior ostium, dark-yellow dots represent His bundle recording site, light-yellow dot indicates the coronary sinus ostium, brown dot denotes the place of radiofrequency application. Ablation was performed using pulsatile radio-frequency applications, hence the relatively large number of applications. 
Discussion
The first finding of the study is that an experienced operator using electroanatomical system is usually able to ablate arrhythmia substrate in pregnant women without the use of X-ray fluoroscopy, even for the positioning of the catheters. However, difficulties in obtaining venous access may occur and may become the main reason for procedure failure. In the literature, mostly single cases of ablation during pregnancy are reported 5, 6 and the presented series of cases is one of the most numerous. Therefore, clinical problems faced by surgeons and unique features of these procedures are inadequately described.
In the study group, about 80% of the arrhythmias were supraventricular tachycardias and 20% were ventricular arrhythmias of the right ventricular outflow tract. That confirms the view presented in the reports of other researchers that supraventricular tachycardias predominate in this group of patients. [6] [7] [8] [9] Pregnant women with WPW syndrome, AT and PJRT constituted 2/3 of the study group, whereas only a small proportion had AVNRT which prevailed in the control group. These results are also consistent with the results of other researchers.
6-9 Table 3 shows the available data in literature about the characteristics of arrhythmias treated with ablation in pregnant women. Analysis of these reports leads to the estimation that the most frequent arrhythmia is WPW syndrome. This data obliges us to pay closer attention to the women with cardiac arrhythmias, and particularly to those with WPW syndrome and AT, because of the high risk of the disease worsening its course during pregnancy.
In the study group, most women were diagnosed with arrhythmia before pregnancy. This observation is consistent with the observation that only less than 4% of women have their first event of arrhythmia during pregnancy. During pregnancy symptoms associated with the occurrence of supraventricular tachycardia get worse in about 29% of patients. The increased levels of sex hormones may result in both the acceleration of the heart rate and the increase of the cardiac output. [17] [18] [19] [20] [21] The analysis of the subgroup of patients with a history of pregnancies in the past helps to draw attention to two important issues. Firstly, exacerbation of the arrhythmia in prior pregnancy indicates the risk of recurrence in a subsequent pregnancy. Therefore, it is advisable to consider ablation even in the case when the arrhythmia symptoms diminish after birth, especially when WPW syndrome, AT or PJRT are found. Secondly, the absence of arrhythmia symptoms in the prior pregnancy does not guarantee their absence in the subsequent pregnancies.
Although commonly used in patients, femoral access is difficult in pregnant women because of the compression of the inferior vena cava by the uterus and related problems in the positioning of the catheters. In our study group, the difficulties in obtaining vascular access became a direct cause of abandoning the procedure in one patient.
The next result of the study is a confirmation of the feasibility of the two stage approach in performing ablation According to the presented study, serious cardiac arrhythmias in pregnant women seem to be rare. However, their incidence may be underestimated due to the lack of awareness among obstetricians and cardiologists that such arrhythmias may be treated with ablation. Therefore, it is very important to raise awareness about the possibility of performing ablation procedures without the use of X-rays in pregnant women.
The main limitation of the study was its retrospective and observational character. Missing or incomplete data present another limitation. The prevalence of serious cardiac arrhythmias in the total population of pregnant women is currently unknown because few doctors are aware of the possibility to perform ablation during pregnancy.
Conclusions
Ablation of arrhythmias in pregnant women constitute about 0.2% of the total number of ablation procedures. For women of reproductive age this percentage is higher and reaches 1%. An experienced surgeon using an electroanatomical system is usually able to ablate arrhythmia substrate without the use of X-ray fluoroscopy, even for positioning of the catheters. The most prevalent causes of arrhythmias in pregnant women requiring ablation are accessory pathways and ATs. In pregnancy, the procedure tailored to the patient's needs should be performed.
